Piper Jaffray Downgrades Novavax (NVAX) to Neutral
- Wall Street drops as healthcare stocks weigh
- Unusual 11 Mid-Day Movers 9/28: (AVXL) (SPU) (HLIT) Higher; (GALT) (TPX) (FGP) Lower
- Bernstein's Sacconaghi Sees Stronger Apple (AAPL) iPhone ASPs
- Fed may change stress tests, capital buffers for U.S. banks: Yellen
- BlackBerry (BBRY) Tops Q2 EPS by 5c; Will End Internal Hardware Development; Boosts FY17 Outlook
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Piper Jaffray downgraded Novavax (NASDAQ: NVAX) from Overweight to Neutral with a price target of $1.00 (from $14.00).
Shares of Novavax closed at $8.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Morgan Stanley Downgrades Shopify (SHOP) to Equalweight Following Recent Gains
- Burlington Stores (BURL): Raising Estimates After Non Deal Roadshow - BMO
- MoffettNathanson Downgrades Discovery Communications (DISCA) to Sell
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Related EntitiesPiper Jaffray
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!